151 related articles for article (PubMed ID: 34140075)
1. [Comparison of plasma levels and immunoactivities of different forms of circulating-free DNA in systemic lupus erythematosus patients].
Huang J; Li Z; Cheng L; Zhang P; Li X; Feng G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):633-640. PubMed ID: 34140075
[TBL] [Abstract][Full Text] [Related]
2. Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response.
Lee JY; Park JK; Lee EY; Lee EB; Song YW
Arthritis Res Ther; 2016 Nov; 18(1):264. PubMed ID: 27852323
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus.
Hartl J; Serpas L; Wang Y; Rashidfarrokhi A; Perez OA; Sally B; Sisirak V; Soni C; Khodadadi-Jamayran A; Tsirigos A; Caiello I; Bracaglia C; Volpi S; Ghiggeri GM; Chida AS; Sanz I; Kim MY; Belmont HM; Silverman GJ; Clancy RM; Izmirly PM; Buyon JP; Reizis B
J Exp Med; 2021 May; 218(5):. PubMed ID: 33783474
[TBL] [Abstract][Full Text] [Related]
4. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
Front Immunol; 2018; 9():322. PubMed ID: 29545790
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.
Yuan W; DiMartino SJ; Redecha PB; Ivashkiv LB; Salmon JE
Arthritis Rheum; 2011 Jan; 63(1):212-8. PubMed ID: 20954190
[TBL] [Abstract][Full Text] [Related]
6. High levels of circulating cell-free DNA are a biomarker of active SLE.
Xu Y; Song Y; Chang J; Zhou X; Qi Q; Tian X; Li M; Zeng X; Xu M; Zhang W; Cram DS; Liu J
Eur J Clin Invest; 2018 Nov; 48(11):e13015. PubMed ID: 30079480
[TBL] [Abstract][Full Text] [Related]
7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
8. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
[TBL] [Abstract][Full Text] [Related]
9. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
Vallin H; Perers A; Alm GV; Rönnblom L
J Immunol; 1999 Dec; 163(11):6306-13. PubMed ID: 10570325
[TBL] [Abstract][Full Text] [Related]
10. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.
Dieker J; Tel J; Pieterse E; Thielen A; Rother N; Bakker M; Fransen J; Dijkman HB; Berden JH; de Vries JM; Hilbrands LB; van der Vlag J
Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137
[TBL] [Abstract][Full Text] [Related]
11. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Raymond WD; Eilertsen GØ; Nossent J
Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
[TBL] [Abstract][Full Text] [Related]
12. Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients.
Tug S; Helmig S; Menke J; Zahn D; Kubiak T; Schwarting A; Simon P
Cell Immunol; 2014; 292(1-2):32-9. PubMed ID: 25243646
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus.
Jeremic I; Djuric O; Nikolic M; Vlajnic M; Nikolic A; Radojkovic D; Bonaci-Nikolic B
Rheumatol Int; 2019 Nov; 39(11):1849-1857. PubMed ID: 31444555
[TBL] [Abstract][Full Text] [Related]
14. Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes.
Mobarrez F; Fuzzi E; Gunnarsson I; Larsson A; Eketjäll S; Pisetsky DS; Svenungsson E
J Autoimmun; 2019 Aug; 102():142-149. PubMed ID: 31103269
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus.
Zhang S; Lu X; Shu X; Tian X; Yang H; Yang W; Zhang Y; Wang G
Intern Med; 2014; 53(24):2763-71. PubMed ID: 25500436
[TBL] [Abstract][Full Text] [Related]
16. EBV load is associated with cfDNA fragmentation and renal damage in SLE patients.
Truszewska A; Wirkowska A; Gala K; Truszewski P; Krzemień-Ojak Ł; Mucha K; Pączek L; Foroncewicz B
Lupus; 2021 Jul; 30(8):1214-1225. PubMed ID: 33866897
[TBL] [Abstract][Full Text] [Related]
17. Clinical algorithm model based on cfDNA to predict SLE disease activity.
Wang F; Liu YJ; Miao HB; Chen Z
Lupus; 2024 Feb; 33(2):145-154. PubMed ID: 38183242
[TBL] [Abstract][Full Text] [Related]
18. Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An
Huang C; Zhang L; Ling F; Wen S; Luo Y; Liu H; Liu J; Zheng W; Liang M; Sun J; Lin YK
Exp Ther Med; 2018 Mar; 15(3):2499-2506. PubMed ID: 29456655
[TBL] [Abstract][Full Text] [Related]
19. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity.
Zhao Q; Yang C; Wang J; Li Y; Yang P
Clin Exp Med; 2017 Nov; 17(4):459-465. PubMed ID: 28039554
[TBL] [Abstract][Full Text] [Related]
20. IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1.
Hagberg N; Berggren O; Leonard D; Weber G; Bryceson YT; Alm GV; Eloranta ML; Rönnblom L
J Immunol; 2011 May; 186(9):5085-94. PubMed ID: 21430220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
